Plerixafor is a hematopoietic stem cell (HSC) mobilizer that inhibits the CXCR4 chemokine receptor and blocks binding of its ligand, stromal cell-derived factor-1-α (SDF-1-α). This agent was approved on Dec. 15, 2008, as treatment in combination with gran
Molecular Spectra
No Data Available
Click here to submit data
References
• Leone, D., et al.: J. Pharmacol. Exp. Ther., 305, 1150 (2000)
• Chigaev, A., et al.: J. Immunol. 178, 6828 (2000)